Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

γδ T cells adapt uniquely to different tissues in mice.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

FOXN1 gene variants cause low T cells and immune issues from birth.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

HIV patients with lower CD4 T cell counts often have more skin problems.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

CD200- cells in hair follicles have a higher ability to regenerate hair.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

The study found that the quality of cord blood units remains consistent before freezing and after thawing, indicating that attached tube segments reliably represent the graft's properties.

CD4+ skin cells may be precursors to basal cell carcinoma.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Supplemental testosterone may lower liver cancer risk in hepatitis C patients.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.